# Adipocyte-Derived Extracellular Vesicles Endow Melanoma Cells with Stem-like Traits via PGC-1α–Mediated Mitochondrial Reprogramming

**Authors:** Gaia Giannitti, Sara Marchesi, Riccardo Garavaglia, Ivan Preosto, Emanuela Carollo, Patrizia Sartori, Fabrizio Fontana

PMC · DOI: 10.3390/antiox15030333 · Antioxidants · 2026-03-06

## TL;DR

Adipocyte-derived extracellular vesicles enhance melanoma aggressiveness by promoting stem-like traits through mitochondrial changes.

## Contribution

Discovery that adipocyte-derived EVs promote melanoma stemness via PGC-1α–mediated mitochondrial reprogramming.

## Key findings

- Adipocyte-derived EVs increase melanoma migration and invasion with mesenchymal marker enrichment.
- EVs induce a stem-like phenotype in melanoma cells, reducing response to BRAF inhibitors.
- Mitochondrial reprogramming via PGC-1α is essential for EV-induced effects, reversible with mitochondrial inhibitors.

## Abstract

Melanoma is an aggressive cancer characterized by a rapid metastatic process. Thus, understanding the mechanisms underlying its progression is urgently needed to improve patient outcomes. In this regard, there is consistent evidence of a tumor-sustaining crosstalk between melanoma and subcutaneous adipose tissue; however, the role of extracellular vesicles (EVs) in this communication still needs to be clarified. We demonstrated that the EVs derived from adipocytes did not alter melanoma cell proliferation but significantly promoted tumor cell migration and invasion by determining an enrichment in mesenchymal markers, such as N-cadherin and vimentin. In particular, these changes were accompanied by the transition towards a stem-like phenotype, characterized by enhanced spherogenic ability and ABCG2 upregulation; interestingly, this led to a reduced in vitro response to the BRAF inhibitor vemurafenib. Mechanistically, an increase in PGC-1α expression was found, resulting in higher mitochondrial mass and activity, ATP synthesis, and ROS overproduction; of note, treatment of melanoma cells with SR-18292 and XCT790, two inactivators of mitochondrial biogenesis, and N-acetylcysteine, a ROS scavenger, successfully counteracted the above EV-related effects, suggesting that mitochondrial function could be targeted to suppress the vesicular interactions between adipose tissue and melanoma. Taken together, these results highlight the crucial role played by EVs in melanoma stroma, pointing out the ability of adipocyte-derived vesicles to sustain cancer aggressiveness via PGC-1α–dependent mitochondrial reprogramming.

## Linked entities

- **Genes:** PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429], CadN (Cadherin-N) [NCBI Gene 35070], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446]
- **Chemicals:** vemurafenib (PubChem CID 42611257), SR-18292 (PubChem CID 129896798), XCT790 (PubChem CID 6918788), N-acetylcysteine (PubChem CID 12035)
- **Diseases:** melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429] {aka ABC15, ABCP, BCRP, BMDP, CD338, CDw338}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, CDH2 (cadherin 2) [NCBI Gene 1000] {aka ACOGS, ADHD8, ARVD14, CD325, CDHN, CDw325}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, VIM (vimentin) [NCBI Gene 7431]
- **Diseases:** cancer (MESH:D009369), Melanoma (MESH:D008545)
- **Chemicals:** ATP (MESH:D000255), N-acetylcysteine (MESH:D000111), vemurafenib (MESH:D000077484), XCT790 (MESH:C488234), SR-18292 (MESH:C000710175), ROS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024706/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024706/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024706/full.md

---
Source: https://tomesphere.com/paper/PMC13024706